Warfarin Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00682 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 48 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | heparin cofactor 2 deficiency | KG + DL |
| 2 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 3 | antithrombin deficiency type 2 | KG + DL |
| 4 | thrombophilia | KG + DL |
| 5 | rheumatoid arthritis | KG + DL |
| 6 | breast fibrocystic disease | KG + DL |
| 7 | benign mammary dysplasia | KG + DL |
| 8 | apocrine adenosis of breast | KG + DL |
| 9 | blunt duct adenosis of breast | KG + DL |
| 10 | migraine disorder | KG + DL |
| 11 | migraine with brainstem aura | KG + DL |
| 12 | brachydactyly-syndactyly syndrome | KG + DL |
| 13 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 14 | breast abscess | KG + DL |
| 15 | fat necrosis of breast | KG + DL |
| 16 | migraine with or without aura, susceptibility to | KG + DL |
| 17 | myocardial infarction | KG + DL |
| 18 | posteroinferior myocardial infarction | KG + DL |
| 19 | posterolateral myocardial infarction | KG + DL |
| 20 | coronary thrombosis | KG + DL |
| 21 | lactation disease | KG + DL |
| 22 | septal myocardial infarction | KG + DL |
| 23 | breast adenosis | KG + DL |
| 24 | congenital coronary artery anomaly | KG + DL |
| 25 | vein disease | KG + DL |
| 26 | lateral sinus thrombosis | KG + DL |
| 27 | cavernous sinus thrombosis | KG + DL |
| 28 | atrophoderma vermiculata | KG + DL |
| 29 | stroke disorder | KG + DL |
| 30 | coronary stenosis | KG + DL |
| 31 | amenorrhea (disease) | KG + DL |
| 32 | sagittal sinus thrombosis | KG + DL |
| 33 | ulerythema ophryogenesis | KG + DL |
| 34 | Prinzmetal angina | KG + DL |
| 35 | idiopathic granulomatous myositis | KG + DL |
| 36 | myositis fibrosa | KG + DL |
| 37 | venous thromboembolism | KG + DL |
| 38 | fibrocartilaginous embolism | KG + DL |
| 39 | tendinitis | KG + DL |
| 40 | myocardial infarction (disease) | KG + DL |
| 41 | angiodysplasia | KG + DL |
| 42 | non-inflammatory vasculopathy | KG + DL |
| 43 | female breast carcinoma | KG + DL |
| 44 | congenital renal artery stenosis | KG + DL |
| 45 | pediatric systemic lupus erythematosus | KG + DL |
| 46 | hemoglobinopathy | KG + DL |
| 47 | osteoarthritis | KG + DL |
| 48 | gout | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.